## Abstract Seven American juvenile patients with undifferentiated or nonkeratinizing nasopharyngeal carcinoma (NPC) were examined serially for Epstein‐Barr virus (EBV)‐specific antibody spectra and titers in sera. At diagnosis, all showed antibody patterns characteristic of NPC: __i.e.__, high tit
Titers of Epstein-Barr Virus-related antibodies in nasopharyngeal carcinoma in japan
✍ Scribed by Akira Tamada; Kazuo Makimoto; Hirohiko Yamabe; Joko Imai; Yorio Hinuma; Akihiro Oyagi; Takashi Araki
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 717 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We examined Epstein-Barr virus (EBV)-specific antibodies in serum samples from 64 and 59 patients with EBV-positive and -negative gastric carcinomas, respectively, and 73 healthy controls using immunofluorescence assays. EBV capsid antigen (VCA) IgG and EBV-determined nuclear antigen (EBNA) IgG were
## Abstract Results are presented of Epstein‐Barr virus‐specific serologic tests for seven Alaskan Native patients with nasopharyngeal carcinoma (NPC) from whom serum had been collected 2–10 years before diagnosis and up to 6 years after diagnosis. The pre‐illness antibody spectra and titers of the
Epstein-Barr virus (EBV) has long been implicated in nasopharyngeal carcinoma (NPC). Recent studies in our and other laboratories have shown a correlation between the disease and high antibody titers to EBV-specific DNase. These data led us to also examine serial sera from healthy adults and patient
## Abstract Sera from 18 tonsillar carcinoma patients and from 18 matched control subjects were examined for the presence of antibodies to viral capsid antigen (VCA), early antigen (EA) and nuclear antigen (EBNA) of EB virus. Antibodies to all three antigens were found more frequently and in signif
## Abstract In order to better understand the relationship between IgA and IgG antibodies to Epstein‐Barr virus (EBV) in nasopharyngeal carcinoma (NPC), we analyzed 230 NPC sera but also a series of sera from patients with other carcinomas selected for their high EBV/IgG antibody titres. We were su